Here's a surprise press release from Allen & Overy, published today and discussed by the IPKat and Merpel
here. The press release is reproduced in full below, with some comments in red:
"Research reveals
growing business support for UPC – crown jewel patents opted in; move to Europe
for major patent disputes
LONDON – Research published by Allen & Overy today demonstrates surprising
support for Europe’s hotly debated Unified Patent Court, with almost
three-quarters (74%) of those responsible for overseeing preparations for the
new system expecting it to be positive for their company – and only 15% expect
it to have negative consequences for them.
While on the big question of whether to opt in or opt out of the new
system during its seven-year transition period, the majority of respondents are
undecided on the bulk of their portfolio (68% on average), close to half (49%)
of those surveyed said they would definitely opt in at least some of their
patents, while only 15% say they would definitely opt out some.
Crucially, where businesses have made a decision to opt in, about 24% of
their portfolio on average, they are deciding to opt in their most valuable, or
crown jewel, patents. This suggests that, where it matters most for business,
they will opt in.
As one Dutch head of IP strategy commented: “The economics of a single
enforcement action outweighs the risk of Europe-wide invalidation.”
As this statement and the research suggest, despite the faltering
reception the new system has received from companies across the globe, its
impact is likely to be significant. The UPC will offer patentees the ability to
obtain broader remedies than those currently on offer in the U.S., with a
larger customer base impacted and injunctions that are easier, cheaper and
quicker to obtain. Costs are estimated to be at least five times lower than in
the U.S.
These advantages alone mean there is likely to be a shift towards
Europe’s UPC as a forum of choice to rival the U.S. for major patent disputes.
This is further supported by the majority of respondents indicating they will
file unitary patents, as opposed to classic European or national patents, under
the new system.
Despite its potential impact on business, the report also highlights an
alarming lack of engagement among senior management on the UPC. Only 13% of
those responsible for preparations for the new regime say their senior
management are ‘fully engaged’ on the issue and appreciate the potential
implications. One consequence of which could see businesses lose exclusivity
for their products, or worse still, have their business or products locked out
of the entire continent.
The scale of the change taking place means that companies cannot prepare
for it overnight. If they don’t engage strategically with the changes now, they
could find their competitors dragging them into UPC or national patent
litigation on their own terms.
While the decision on what to do with a companies’ most valuable patents
seems clear, what to do with a business’s less valuable patents is anything
but. The 68%, on average, of their portfolio that business are still undecided
on is largely made up of their secondary patents. Lack of clarity on costs is
cited as the main barrier to being able to make decisions according to
two-thirds (67%) of respondents. Only when this is clarified will businesses be
able to undertake a proper cost-benefit analysis on their less valuable patents
and whether it is more economically beneficial to opt them in or out".
At this point, the statistics stop and the comment begins:
"As well as clarity on costs, there is a pressing need to clarify a few areas
where interpretations of the rules differ. This risks leaving companies with
dangerous gaps in the understanding of the strategic implications of their
decisions [The words 'risk', 'pressing need' and 'dangerous gaps' are interesting here: would the level of willingness to commit 'crown jewel' patents or to express confidence in the new system have been the same if these points had been addressed to respondents before they completed the survey? Or would they consider that the new system merely replaces one set of risks and uncertainties with another, exchanging 'known unknowns' for 'unknown unknowns'?]. In particular what happens to patents that have not been formally
opted out of the UPC? These “opt-in orphans” can be litigated during the
transitional period in either the national courts or the UPC. But it is not
clear what happens after proceedings have been completed and whether national
court proceedings could effectively opt them out of the UPC for the life of the
patent. An extreme example would be a pharmaceutical generic company launching
a revocation action against, for example, the Latvian part of a blockbuster
patent. The company could then withdraw the action, having effectively forced
the patentee out of the UPC system. This goes entirely contrary to the original
intention to leave as many patents as possible in the system [Is this a temporary evil, as it were, which it's worth tolerating on political grounds for the sake of post-transitional period gains, or is it more serious than that?]. Another
interpretation of the rules could also see the possibility of concurrent
litigation in both the UPC and national courts which could lead to
contradictory decisions if, for example, a national court upholds a patent and
the UPC revokes it. This is the very type of clash the UPC is designed to
avoid [but it's quite akin to the sort of contradictory judicial decision-making which patent owners and their foes have lived with since the European patent came into our lives: it's undesirable, certainly, but the fact is that most businesses have managed to cope]. Greater clarity is urgently required for these “opt-in orphans”.
Commenting, Geert Glas, head of Allen & Overy’s IP practice said:
“Companies cannot afford to wait until they have an absolute and final answer
to every question [Never was a truer word spoken: we still await absolute and final answers to many questions arising out of the now-mature Community trade mark system ...]. There is now evidence enough for them to decide whether or
not to use the system [Unfortunately much of this evidence, being speculative, is of little probative value -- and may spark off different evaluations depending on the industrial sector concerned and whether it's at its green field stage or taping out into a series of incremental improvements over a long-established technology]. Time is running out before the UPC becomes active.
Companies can’t afford to hesitate over one of the bigger strategic decisions
their organisations will face for many years."”
No comments:
Post a Comment